title: Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.
abstract: BACKGROUND
  A synergistic effect resulting from a combination of BCL2 and MYC or MYC and CCND1 has been implicated in human B-cell lymphomas. Although the identification of other cooperative genes involved is important, our present understanding of such genes remains scant. The objective of this study was to identify the additional cooperative gene(s) associated with BCL2 and MYC or MYC and CCND1. First, we assessed whether Bcl2, Myc and Ccnd1 could cooperate. Next, we developed a synergism-based functional screening method for the identification of other oncogene(s) that act with Bcl2 and Myc.
  
  
  METHODS
  Growth in culture, colony formation and oncogenicity in vivo were assessed in mouse primary B cells exogenously expressing various combinations of Bcl2, Myc and Ccnd1. For the functional screening, Bcl2- and Myc-expressing primary B cells were infected with a retroviral cDNA library. Inserted cDNA of transformed cells in culture were then identified.
  
  
  RESULTS
  Primary B cells exogenously expressing Bcl2, Myc and Ccnd1 showed factor-independent growth ability, enhanced colony-forming capability and aggressive oncogenicity, unlike the cases observed with the expression of any combination of only two of the genes. We identified CCND3 and NRAS as cooperative genes with Bcl2 and Myc through the functional screening.
  
  
  CONCLUSIONS
  Bcl2, Myc and Ccnd1 or Bcl2, Myc and CCND3 synergistically transformed mouse primary B cells into aggressive malignant cells. Our new synergism-based method is useful for the identification of synergistic gene combinations in tumor development, and may expand our systemic understanding of a wide range of cancer-causing elements.
authors: Division of Molecular Medicine, Aichi Cancer Center Research Institute, Chikusa-ku, Nagoya, Japan.
authors: Masao
authors: M
authors: Nakagawa
authors: Shinobu
authors: S
authors: Tsuzuki
authors: Keiichiro
authors: K
authors: Honma
authors: Osamu
authors: O
authors: Taguchi
authors: Masao
authors: M
authors: Seto
references: J Clin Invest. 1989 Nov;84(5):1454-9
references: 2509518
references: Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8886-91
references: 12077300
references: N Engl J Med. 2008 Nov 27;359(22):2313-23
references: 19038878
references: Genes Chromosomes Cancer. 1990 Jul;2(2):147-58
references: 2278969
references: N Engl J Med. 1988 May 26;318(21):1373-8
references: 3285208
references: Leukemia. 1999 Sep;13(9):1335-42
references: 10482983
references: EMBO J. 1988 May;7(5):1337-43
references: 3261687
references: Nat Rev Cancer. 2002 Oct;2(10):764-76
references: 12360279
references: Hepatology. 2008 Jul;48(1):252-64
references: 18571787
references: Clin Cancer Res. 2005 Dec 1;11(23):8265-72
references: 16322284
references: Clin Cancer Res. 2009 Jan 1;15(1):30-8
references: 19118030
references: Oncogene. 2001 Sep 10;20(40):5580-94
references: 11607811
references: N Engl J Med. 2004 Nov 18;351(21):2159-69
references: 15548776
references: J Pathol. 1998 Jun;185(2):159-66
references: 9713342
references: Proc Natl Acad Sci U S A. 1988 Dec;85(23):9268-72
references: 3057505
references: Genes Dev. 2002 Dec 15;16(24):3277-89
references: 12502747
references: Nat Med. 2004 Aug;10(8):789-99
references: 15286780
references: Blood. 2010 Jan 14;115(2):289-95
references: 19901260
references: EMBO J. 1991 Feb;10(2):327-36
references: 1991449
references: Cancer Cell. 2003 Feb;3(2):185-97
references: 12620412
references: Cancer Sci. 2009 Feb;100(2):233-7
references: 19038003
references: Oncogene. 1989 May;4(5):575-81
references: 2657573
references: Int J Hematol. 2004 Jun;79(5):474-9
references: 15239399
references: Blood. 2001 Nov 1;98(9):2837-44
references: 11675358
references: J Exp Med. 1999 May 3;189(9):1399-412
references: 10224280
references: Blood. 2011 Feb 24;117(8):2319-31
references: 21119107
references: Blood. 2009 Sep 10;114(11):2273-9
references: 19597184
references: Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8443-8
references: 15155899
references: Cell. 2004 Jan 23;116(2):205-19
references: 14744432
references: Blood. 1995 Nov 15;86(10):3905-14
references: 7579360
references: Genes Chromosomes Cancer. 2011 Jan;50(1):43-50
references: 20960563
references: Cancer Res. 1999 Apr 1;59(7 Suppl):1685s-1692s
references: 10197581
references: Cell. 2004 Aug 20;118(4):477-91
references: 15315760
references: Nat Rev Cancer. 2002 Sep;2(9):647-56
references: 12209154
references: Clin Cancer Res. 2002 Mar;8(3):729-33
references: 11895902
references: Nature. 2004 Nov 18;432(7015):298-306
references: 15549091
references: Exp Hematol. 2003 Nov;31(11):1007-14
references: 14585362
references: Blood. 1992 Aug 1;80(3):758-67
references: 1638027
references: Nature. 2007 Jul 26;448(7152):445-51
references: 17597761
references: Blood. 2005 Dec 15;106(13):4315-21
references: 16123218
references: Blood. 2008 Jun 15;111(12):5683-90
references: 18391076